Olaf Mercier is an expert in Pulmonology at Hôpital Marie Lannelongue (France). As of October 2026, ScienceLeadR ranks Olaf Mercier in the top 1% of experts worldwide for Hypertension and Hypertension, Pulmonary. Olaf Mercier has authored 485 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 2 of them ongoing. SLR score: 1,725 (community average: 125). How the SLR is computed.

LeadR Profile

Olaf Mercier Hôpital Marie Lannelongue France
1 725 ScienceLeadR Reputation 1725
Network Map

Pulmonology

Subspecialties: Transplantation - Thoracic And Cardiovascular Surgery - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2005 - 2026

Source: PubMed

Hôpital Marie Lannelongue

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Evolving profile and outcomes of patients with pulmonary arterial hypertension undergoing lung transplantation.
PMID 42780297 — hypertension, lung, heart, extracorporeal membrane oxygenation, aged, pulmonary arterial hypertension, transplants, lung transplantation, transplantation
JHLT Open20260
Prolonged ex vivo lung perfusion with corrected perfusate: functional and structural benefits in swine.
PMID 42688299 — lung, solutions, transplants
Front Transplant20260
Right ventricular remodeling and circulating metabolic profiles of patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy.
PMID 42502728 — hypertension, ventricular remodeling, hypertension, pulmonary, arginine, fibrosis, hypertrophy, biomarkers, metabolomics, histology, endarterectomy, lysine, myocytes, cardiac, fatty acids
JHLT Open20260
Bridging strategies for heart-lung transplantation: Current concepts and mechanical support modalities.
PMID 42256243 — lung, heart-lung transplantation, heart, extracorporeal membrane oxygenation, lung transplantation, transplantation
JHLT Open20260
The importance of Post-Processing Methods for Assessing Right Ventricular Volumes and Function in Patients with Pulmonary Hypertension: results from the PRINCEPT study.
PMID 42134497 — hypertension, hypertension, pulmonary
Chest20260

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Chair: 1

By phase:

N/A 10
Phase 3 2

By status:

Unknown 6
Completed 4
Recruiting 2

By type:

Interventional 10
Observational 2

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 3
multicentric5to9 0
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Veno arterial ExtraCorporeal Membrane Oxygenation to Reduce Morbidity and Mortality Following Lung TransPlant
NCT05664204 — mortality, lung, extracorporeal membrane oxygenation, drug-related side effects and adverse reactions, transplants, morbidity, ventilation, membranes
N/ARecruiting2024
Gustave Roussy Cancer Profiling
NCT04932525 — blood, neoplasms, biopsy, research
N/ARecruiting2021

LeadR Networks

Main global connection map